$2.39
0.09[3.91%]
At close: Apr 26
$2.39
0[0.00%]
After Hours: 4:00PM EDT
Taysha Gene Therapies
(NASDAQ:TSHA)Latest News for Taysha Gene Therapies Stock (NASDAQ:TSHA)
Taysha Gene Therapies Stock (NASDAQ: TSHA)
Categories: All
Friday, April 19, 2024
Thursday, April 18, 2024
Friday, April 12, 2024
Thursday, April 11, 2024
Wednesday, April 10, 2024
Tuesday, April 09, 2024
- Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Apr 9, 2024, 1:12PM
- BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On TuesdayAvi Kapoor - Apr 9, 2024, 10:43AM
- Evaluating Taysha Gene Therapies: Insights From 7 Financial AnalystsBenzinga Insights - Apr 9, 2024, 8:01AM
- Taysha Gene Therapies shares are trading higher after Piper Sandler initiated coverage on the stock with an Overweight rating and a price target of $9.Benzinga Newsdesk - Apr 9, 2024, 7:17AM
- Piper Sandler Initiates Coverage On Taysha Gene Therapies with Overweight Rating, Announces Price Target of $9Benzinga Newsdesk - Apr 9, 2024, 6:47AM
Thursday, March 21, 2024
- Spinal Delivery Of Taysha's Gene Therapy Shows Promise In Rare Childhood Neurodegenerative DiseaseVandana Singh - Mar 21, 2024, 12:36PM
- Canaccord Genuity Reiterates Buy on Taysha Gene Therapies, Maintains $7 Price TargetBenzinga Newsdesk - Mar 21, 2024, 11:37AM
- Micron To Rally Around 134%? Here Are 10 Top Analyst Forecasts For ThursdayAvi Kapoor - Mar 21, 2024, 9:15AM
- Chardan Capital Maintains Buy on Taysha Gene Therapies, Raises Price Target to $7Benzinga Newsdesk - Mar 21, 2024, 4:51AM
Wednesday, March 20, 2024
- Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - Mar 20, 2024, 2:03PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Mar 20, 2024, 1:31PM
- Sportradar Group Posts Upbeat Earnings, Joins Kingsoft Cloud, Braskem And Other Big Stocks Moving Higher On WednesdayAvi Kapoor - Mar 20, 2024, 11:41AM
- Taysha Gene Therapies Shares Jump On Initial Data From First Pediatric Patient With Rare Neurodevelopmental DisorderVandana Singh - Mar 20, 2024, 10:22AM
- JMP Securities Reiterates Market Outperform on Taysha Gene Therapies, Maintains $5 Price TargetBenzinga Newsdesk - Mar 20, 2024, 9:44AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Mar 20, 2024, 9:05AM
- Cantor Fitzgerald Reiterates Overweight on Taysha Gene Therapies, Maintains $7 Price TargetBenzinga Newsdesk - Mar 20, 2024, 8:58AM
- Market-Moving News for March 20thBenzinga Newsdesk - Mar 20, 2024, 8:39AM
- Taysha Gene Therapies shares are trading higher after the company reported a year-over-year increase in FY23 EPS results and provided corporate and clinical updates.Benzinga Newsdesk - Mar 20, 2024, 8:29AM
- Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Mar 20, 2024, 8:20AM
- Needham Maintains Buy on Taysha Gene Therapies, Raises Price Target to $7Benzinga Newsdesk - Mar 20, 2024, 7:03AM
Tuesday, March 19, 2024
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga Insights - Mar 19, 2024, 5:34PM
- Taysha Gene Therapies Stock Soars On FY23 Results: Here's WhyErica Kollmann - Mar 19, 2024, 5:07PM
- Taysha Gene Therapies: Q4 Earnings InsightsBenzinga Insights - Mar 19, 2024, 4:35PM
- Taysha Gene Therapies shares are trading higher after the company reported a year-over-year increase in FY23 EPS results.Benzinga Newsdesk - Mar 19, 2024, 4:25PM
- Taysha Gene Therapies FY23 EPS $(0.96) Vs $(3.78) YoY; As Of December 31, 2023, Taysha Had $143.9M In Cash And Cash EquivalentsBenzinga Newsdesk - Mar 19, 2024, 4:03PM
- Earnings Scheduled For March 19, 2024Benzinga Insights - Mar 19, 2024, 6:06AM
Monday, March 18, 2024
Friday, March 01, 2024
Thursday, February 29, 2024
Thursday, February 15, 2024
Monday, January 22, 2024
Wednesday, January 10, 2024
Tuesday, December 19, 2023
Monday, December 18, 2023
Wednesday, November 29, 2023
Tuesday, November 21, 2023
Monday, November 20, 2023
Wednesday, November 15, 2023
- Taysha Gene Therapies shares are trading higher after the company reported Q3 financial results. Also, Cantor Fitzgerald maintained an Overweight rating on the stock and raised its price target from $6 to $7.Benzinga Newsdesk - Nov 15, 2023, 2:13PM
- Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Nov 15, 2023, 2:04PM
- Dow Rises Over 100 Points; Target Posts Upbeat EarningsLisa Levin - Nov 15, 2023, 12:20PM
- US Stocks Gain; Producer Prices Fall In OctoberLisa Levin - Nov 15, 2023, 9:57AM
- 4 Analysts Have This to Say About Taysha Gene TherapiesBenzinga Insights - Nov 15, 2023, 9:00AM
- Cantor Fitzgerald Maintains Overweight on Taysha Gene Therapies, Raises Price Target to $7Benzinga Newsdesk - Nov 15, 2023, 8:59AM